In a more recent study, we carried out a comprehensive analysis of over 2700 neurons examined from twelve MS compared to six healthy control brains showed nucleocytoplasmic mislocalization of hnRNP A1 and TDP−43 statistically distinguished MS from control cases (Salapa et al., 2020). The gene discussed is TARDBP; the disease is myeloid sarcoma.